Malignant Male Reproductive System Neoplasm

Malignant Male Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,451
Recruiting: 785
Ph III recruiting: 82
Growth YoY: +24.3%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (762)

clinicaltrialsPublishedShowing 251–300 of 1,961 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04619069	Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer	active not recruiting	Phase 1 / Phase 2	60	Sunnybrook Health Sciences CentreOTHER	1	Jun 26, 2026	clinicaltrials
NCT01251861	Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer	completed	Phase 2	108	National Cancer Institute (NCI)NIH	2	Jun 25, 2026